Stock Market News

H.C. Wainwright reiterates buy rating on Anixa Biosciences stock

Jun 25, 2025 - 12:42
 0
H.C. Wainwright reiterates buy rating on Anixa Biosciences stock
Read More

Tags:

Previous Article

Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibody

Next Article

Sangamo stock holds Buy rating at H.C. Wainwright on Fabry therapy data

Related Posts

European stocks slide; EU/U.S. trade talks in focus

European stocks slide; EU/U.S. trade talks in focus

May 28, 2025  0

Tesla Europe sales slide 28% in May even as broader EV ...

Jun 25, 2025  0

AI Mode takes center stage at I/O 2025 as Google seeks ...

May 20, 2025  0